BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25975210)

  • 1. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
    Mosavi F; Laurell A; Ahlström H
    Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
    Gu J; Chan T; Zhang J; Leung AY; Kwong YL; Khong PL
    AJR Am J Roentgenol; 2011 Sep; 197(3):W384-91. PubMed ID: 21862763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
    Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
    Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Body Diffusion Imaging Applying Simultaneous Multi-Slice Excitation.
    Kenkel D; Wurnig MC; Filli L; Ulbrich EJ; Runge VM; Beck T; Boss A
    Rofo; 2016 Apr; 188(4):381-8. PubMed ID: 26815283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
    Michielsen K; Vergote I; Op de Beeck K; Amant F; Leunen K; Moerman P; Deroose C; Souverijns G; Dymarkowski S; De Keyzer F; Vandecaveye V
    Eur Radiol; 2014 Apr; 24(4):889-901. PubMed ID: 24322510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
    De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
    BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Whole-Body Diffusion-Weighted Imaging Compared to PET-CT Plus Brain MRI in Staging Clinically Resectable Lung Cancer.
    Usuda K; Sagawa M; Maeda S; Motono N; Tanaka M; Machida Y; Matoba TM; Watanabe N; Tonami H; Ueda Y; Uramoto H
    Asian Pac J Cancer Prev; 2016; 17(6):2775-80. PubMed ID: 27356689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.
    Han SN; Amant F; Michielsen K; De Keyzer F; Fieuws S; Van Calsteren K; Dresen RC; Gziri MM; Vandecaveye V
    Eur Radiol; 2018 May; 28(5):1862-1874. PubMed ID: 29218610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
    van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM
    AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
    Li B; Li Q; Nie W; Liu S
    Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S; Xue HD; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.
    Michielsen KL; Vergote I; Dresen R; Op de Beeck K; Vanslembrouck R; Amant F; Leunen K; Moerman P; Fieuws S; De Keyzer F; Vandecaveye V
    Br J Radiol; 2016 Nov; 89(1067):20160468. PubMed ID: 27585490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
    Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
    Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
    Li S; Sun F; Jin ZY; Xue HD; Li ML
    J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy.
    Paruthikunnan SM; Kadavigere R; Karegowda LH
    AJR Am J Roentgenol; 2017 Sep; 209(3):477-490. PubMed ID: 28678578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
    Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.